Penicillin and Metronidazole in Treatment of Peritonsillar Abscess
- Conditions
- Peritonsillar Abscess
- Interventions
- Registration Number
- NCT01255670
- Lead Sponsor
- Helsinki University Central Hospital
- Brief Summary
Treatment of peritonsillar abscess varies. To study whether broad spectrum antibiotics are required in addition to abscess drainage, a prospective, double blind, placebo-controlled, randomized study on 200 adult patients with peritonsillar abscess is performed. 100 patients are given penicillin and metronidazole and 100 patients get penicillin and placebo. Recovery and recurrence are analyzed.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 200
- referring doctor suspects peritonsillar abscess
- patient is voluntary
- patient has daily access to his/her e-mail
- patient speaks and understands Finnish of Swedish
- female patients have adequate birth-control method
- patient has peritonsillar abscess
- allergy to penicillin
- allergy to metronidazole
- use of metronidazole in preceding one month
- pregnancy
- breast-feeding
- renal insufficiency
- liver insufficiency
- alcoholism (drunk at least once a week)
- participant in another clinical trial at the moment
- treatment of peritonsillar abscess requires in-patient care
- tonsillectomy during the next 30 days
- army recruit
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description penicillin and metronidazole penicillin and metronidazole in peritonsillar abscess After incision and drainage 100 randomized patients receive penicillin and metronidazole as treatment of peritonsillar abscess penicillin and placebo penicillin and metronidazole in peritonsillar abscess After incision and drainage 100 randomized patients receive penicillin and placebo as treatment of peritonsillar abscess
- Primary Outcome Measures
Name Time Method Number of Participants With Recurrence of Peritonsillar Abscess 56 days Number of participants with recurrence of peritonsillar abscess having metronidazole in addition to penicillin or penicillin and placebo.
- Secondary Outcome Measures
Name Time Method Number of Participants Recovering From Peritonsillar Abscess 28 days Number of participants recovering from peritonsillar abscess having metronidazole in addition to penicillin or penicillin and placebo.
Trial Locations
- Locations (1)
Helsinki University Central Hospital
🇫🇮Helsinki, Finland